You can view the research column published every month by SMC Laboratories.
2025.02.03
RNA sequencing data from STAM mice
We would like to introduce the acquisition of RNA sequencing data from STAMTM mice which we hope to utilize to…
READ MORE
2025.02.03
Nerandomilast: Breakthrough Success in Phase 3
We would like to introduce the data we obtained from a recently conducted bleomycin-induced lung fibrosis stud…
READ MORE
2025.02.02
Comparative Study of GLP-1 Agonists
Direct comparison study with GLP-1 agonist Today, we would like to introduce a demonstration example of…
READ MORE
2025.02.02
Comparative Study of FGF21 agonist
Direct comparison study with FGF21 agonist Today, we would like to introduce a demonstration example of…
READ MORE
2025.02.02
Sample delivery service of disease model mice
Today, we would like to proposal on how to utilize samples of our disease model mice. We have provided …
READ MORE
2025.02.02
Comparison data between NASH-HCC patients and our NASH-HCC model
We have acquired the gene expression data (RNA-seq data) using our STAMTM model. Additionally, we have compare…
READ MORE
2025.02.02
Drug Efficacy Studies in NASH Mouse Model
Today, we would like to introduce a study published by our client, Tsumura, in which they used our pre-clinica…
READ MORE
2025.02.02
In-vivo screening and pharmacology study for liver cancer
We would like to introduce an in-vivo screening study using our liver orthotopic xenograft and STAM™ models. I…
READ MORE
2025.02.02
Pre-clinical studies for Liver Cancer: STAM model
For Today’s topic, I would like to focus on Hepatocellular Carcinoma (HCC). We have summarized the chara…
READ MORE
2025.02.02
Characterization of a lung fibrosis model and its usefulness
We offer the Idiopathic Pulmonary Fibrosis (IPF) model as a potential model for the development of therapeutic…
READ MORE
